Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
LIN — Linde plc
NASDAQ
FULL STOCK PAGE →

Linde Q1 2026 Earnings Call Summary

MAY 1, 2026 2 MIN READ
REVENUE
$8.78B +0.2%
NET MARGIN
21.1% +3.2 PTS
EPS
$4.00 +22.0%
FREE CASH FLOW
$898.0M -42.9%

1Key Financial Results and Metrics

Earnings Per Share (EPS): $4.33, up 10% year-over-year.

Operating Margin: 30%, consistent with the prior year.

Return on Capital: 24%, reflecting strong capital discipline.

Sales: $8.8 billion, an 8% increase year-over-year, flat sequentially.

Operating Profit: $2.6 billion, also up 8% year-over-year.

Operating Cash Flow: $2.2 billion, a 4% increase from the previous year.

Free Cash Flow: $900 million, primarily used for dividends and share repurchases.

Capital Expenditures: $1.3 billion, split between maintenance and project backlog.

2Strategic Updates and Business Highlights

Market Performance:

Healthcare sales grew 1% year-over-year, with U.S. home care flat due to policy changes.

Food and beverage sales increased 5%, driven by U.S. beverage demand.

Electronics sales rose 10%, fueled by investments in advanced chip production.

Industrial markets showed growth, particularly in the Americas, but faced challenges in EMEA.

Project Backlog: Ended the quarter at $7.1 billion, with significant investments in ultra-high purity plants.

Acquisitions: Signed nine bolt-on acquisitions in the Americas, enhancing future EPS growth.

3Forward Guidance and Outlook

Q2 EPS Guidance: Expected in the range of $4.40 to $4.50, representing 8% to 10% growth.

Full Year EPS Guidance: Updated to $17.60 to $17.90, or 7% to 9% growth, with a 1% currency benefit included.

Market Assumptions: Guidance assumes no economic improvement at the midpoint, with potential upside from helium market recovery.

4Bad News, Challenges, or Points of Concern

Geopolitical Risks: Ongoing Middle East conflict impacting EMEA volumes and creating uncertainty in industrial demand.

Healthcare Segment: U.S. home care business remains flat due to recent policy changes, affecting growth expectations.

Helium Supply Issues: While Linde is well-positioned, global shortages could impact pricing and availability, with potential delays in securing long-term contracts.

Regional Disparities: EMEA continues to face weak industrial activity, contrasting with stronger performance in the Americas.

Cost Inflation: Rapid cost inflation in March created temporary margin pressures, particularly in Europe.

5Notable Q&A Insights

Margins: Improvement expected in the Americas, but EMEA remains a concern due to weak industrial activity and geopolitical impacts.

Commercial Space: Linde is optimistic about growth in the commercial space sector, with potential for reaching $1.7 billion in sales sooner than previously expected.

Volume Landscape: The Americas show positive trends, while EMEA struggles; APAC remains neutral.

Helium Market Dynamics: Incremental volume opportunities exist through long-term contracts, but pricing adjustments depend on the duration of supply disruptions.

Project Delays: No significant delays in the current project backlog, but potential new projects may face geographic-specific challenges. Overall, Linde's Q1 2026 results reflect solid growth amid a challenging economic backdrop, with cautious optimism for future performance tempered by geopolitical uncertainties and sector-specific challenges.

SOURCE: Q1 2026 EARNINGS CALL TRANSCRIPT